Shawinski

Google: A Gorilla Not to Be Missed

A recent Globe and Mail article supports this view on MS;TSX: 'Eye on Equities: Stocks that should be on your radar screen' - www.theglobeandmail.co.../


On Dec 31 09:23 AM PeakOiler wrote:

> GOOG won't be matching your 60% return on OMRI so here's a suggestion:
> MS on Toronto. BioMS (MS = multiple sclerosis) has a patented and
> apparently very effective, safe drug for later stage MS, now in Phase
> III. Lilly (seekingalpha.com/symbo...) has injected $100M,
> with more to come, into the company, and the top drug analysts in
> Canada are expecting a buyout by Lilly at a huge premium to the $320
> CDN market cap.
>
> Added bonus: currency diversification.